Literature DB >> 23276185

Fibrous dysplasia.

Nicole D Riddle1, Marilyn M Bui.   

Abstract

Fibrous dysplasia is an uncommon bone disease. The diagnosis is usually not difficult, given the symptoms, radiology, and histology. The gene involved is the α subunit of the G-protein receptor. Recent innovation in molecular pathology has helped us understand the mechanism of disease pathogenesis. The treatment of fibrous dysplasia is limited to maintenance of maximum bone density. Surgical reinforcement is used to treat bowing deformities and fractures as they occur. Malignant transformation of fibrous dysplasia is rare. Currently, there is no therapy for preventing the disease from advancing or for malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23276185     DOI: 10.5858/arpa.2012.0013-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  30 in total

Review 1.  Percutaneous Treatments of Benign Bone Tumors.

Authors:  Guillaume Koch; Roberto Luigi Cazzato; Andrew Gilkison; Jean Caudrelier; Julien Garnon; Afshin Gangi
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

2.  Mutational analysis of high-grade spindle cell sarcoma of the femur in Mazabraud's syndrome.

Authors:  Michele Calleja; Fernanda Amary; Paul O'Donnell
Journal:  Skeletal Radiol       Date:  2018-05-27       Impact factor: 2.199

3.  Malignant sarcomatous transformation of fibrous dysplasia.

Authors:  Stacey K Mardekian; Madalina Tuluc
Journal:  Head Neck Pathol       Date:  2014-08-27

4.  Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA).

Authors:  M Hagelstein-Rotman; M E Meier; B C J Majoor; A H G Cleven; P D S Dijkstra; N A T Hamdy; M A J van de Sande; O M Dekkers; N M Appelman-Dijkstra
Journal:  Calcif Tissue Int       Date:  2020-11-23       Impact factor: 4.333

5.  Pagetoid polyostotic fibrous dysplasia.

Authors:  Rashmi Maruti Hosalkar; Jigna Pathak; Niharika Swain; Neeta Mohanty
Journal:  BMJ Case Rep       Date:  2015-05-12

6.  Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia.

Authors:  Cristina Eller-Vainicher; Diego Sergio Rossi; Giuseppe Guglielmi; Giada Anna Beltramini; Elisa Cairoli; Antonio Russillo; Giovanna Mantovani; Anna Spada; Iacopo Chiodini
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

Review 7.  DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome.

Authors:  Luis F de Castro; Diana Ovejero; Alison M Boyce
Journal:  Eur J Endocrinol       Date:  2020-05       Impact factor: 6.664

Review 8.  Osteoclasts: more than 'bone eaters'.

Authors:  Julia F Charles; Antonios O Aliprantis
Journal:  Trends Mol Med       Date:  2014-07-06       Impact factor: 11.951

9.  Management of congenital pseudarthrosis of the tibia with the Ilizarov method in a paediatric population: influence of aetiological factors.

Authors:  Dmitry Y Borzunov; Alexander Y Chevardin; Alexander I Mitrofanov
Journal:  Int Orthop       Date:  2015-11-07       Impact factor: 3.075

Review 10.  Benign tumours of the bone: A review.

Authors:  David N Hakim; Theo Pelly; Myutan Kulendran; Jochem A Caris
Journal:  J Bone Oncol       Date:  2015-03-02       Impact factor: 4.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.